Metformin Does Not Improve Pregnancy Outcomes in Heavy Women Metformin Does Not Improve Pregnancy Outcomes in Heavy Women
Adding metformin to diet and lifestyle advice does not improve pregnancy or birth outcomes in women who are overweight or obese, according to a clinical trial from Australia.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Statins are being overprescribed, study suggests
The risks of statins for primary prevention are greater than the benefits for many patients Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Direct oral anticoagulants as safe as warfarin after VTE Too few women take part in many CVD clinical trials Use of DPP-4 inhibitors associated with increased risk of IBD Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2018 Category: UK Health Source Type: news

Adding Metformin to Tamoxifen to Protect the Endometrium Adding Metformin to Tamoxifen to Protect the Endometrium
Might the addition of metformin help mitigate the endometrial effects of tamoxifen therapy?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 3, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Metformin and Risk of HCC in Patients With T2DM Metformin and Risk of HCC in Patients With T2DM
Is metformin use associated with a reduced risk of hepatocellular carcinoma in patients with type 2 diabetes mellitus?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 3, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Metformin's Effect in Diabetes Linked to Gut Microbiota Changes Metformin's Effect in Diabetes Linked to Gut Microbiota Changes
New research links changes in gut microbiota and intestinal farnesoid X receptor with metformin's clinical benefits in diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

No link between pancreatic diseases and incretins in type-2 diabetes
Research, published inDiabetic Medicine, suggests that incretins do not increase the risk of pancreatic diseases in type-2 diabetes patients treated with metformin.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 29, 2018 Category: Endocrinology Source Type: news

Detection of vitamin B12 deficiency in type-2 diabetes patients may lower nerve damage risk
Research, presented at the Society for Endocrinology annual conference, suggests that screening for vitamin B12 deficiency in type-2 diabetes patients, treated with metformin, can reduce their risk of developing nerve damage.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 23, 2018 Category: Endocrinology Source Type: news

Improved Mobility With Metformin in Myotonic Dystrophy Type 1 Improved Mobility With Metformin in Myotonic Dystrophy Type 1
This Phase II RCT showed promise for metformin for improving the mobility of patients with myotonic dystrophy type 1, the most common form of muscular dystrophy in adults.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Segluromet (Ertugliflozin and Metformin Hydrochloride Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 8, 2018 Category: Drugs & Pharmacology Source Type: news

Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication
Metformin use is associated with a lower risk of gastric cancer in diabetic patients after eradication of H. pylori, researchers from Hong Kong report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Can you eat grapefruit while taking metformin?
Consuming grapefruit or grapefruit juice can affect the safety and effectiveness of a variety of drugs. However, there is little evidence to suggest people taking metformin should avoid grapefruit. Learn more. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 7, 2018 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news

Insulin and metformin may lower severity of Alzheimer ’s disease
Research, published inPLOS One, suggests that insulin and metformin may preserve blood vessels in the brain, lowering the severity of Alzheimer’s disease.Daily Mail  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 2, 2018 Category: Endocrinology Source Type: news

World Diabetes Day
14 November is World Diabetes Day, which is an annual campaign increase awareness of the diseaseWorld Diabetes Day, on the 14th November every year. The theme for World Diabetes Day 2018 is The Family and Diabetes. The aim is to raise awareness of the impact that diabetes has on the family and support network of those affected, as well as promoting the role of the family in the management, care, prevention and education of diabetes.The Cochrane Metabolic and Endocrine Disorders group's main area of work is the evaluation of the effects of health-care interventions relevant to the prevention, treatment or management, and re...
Source: Cochrane News and Events - November 1, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Diabetes drugs can reduce the severity of Alzheimer's
Examining blood vessels in the brains of people with both conditions, Icahn School of Medicine researchers found those of people treated with metformin and other drugs were in a better state. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2018 Category: Consumer Health News Source Type: news

Treatment of hypertension for low-risk patients questioned
Study funds little evidence of benefits from treatment Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Avoid BP-lowering drugs in stroke Adding insulin to metformin linked to higher mortality Stroke rate higher in HIV patients Recurrent stroke more likely at very low BP (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2018 Category: UK Health Source Type: news

Metformin lowers age-related macular degeneration risk
Research, presented at the American Academy of Ophthalmology Meeting, suggests that patients with type-2 diabetes who use metformin lower their risk of developing age-related macular degeneration. Med Page Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 29, 2018 Category: Endocrinology Source Type: news

Metformin May Cut AMD Risk in Diabetes
(MedPage Today) -- Almost a 50% risk reduction versus nonusers (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 29, 2018 Category: Endocrinology Source Type: news

New mechanism by which metformin treats diabetes
Research, published inThe FASEB Journal, suggests that metformin reduces SHIP2 activity, increasing insulin signalling and glucose uptake in cells.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 24, 2018 Category: Endocrinology Source Type: news

Medical News Today: Is hair loss a side effect of metformin?
Doctors prescribe metformin to treat people with type 2 diabetes or polycystic ovary syndrome (PCOS). In rare cases, metformin may cause hair loss. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 22, 2018 Category: Consumer Health News Tags: Diabetes Source Type: news

Metformin may protect against heart disease in type-1 diabetics
Research, published in theInternational Journal of Molecular Sciences, suggests that metformin can improve the body’s ability to repair damaged blood vessels, by lowering miR-222, miR-195 and miR-21a levels in type-1 diabetes patients.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 22, 2018 Category: Endocrinology Source Type: news

Gastric Band, Metformin Equally Prevent Diabetes in Short-Term Gastric Band, Metformin Equally Prevent Diabetes in Short-Term
In moderately obese adults with prediabetes or recent-onset type 2 diabetes, both gastric banding and metformin improved insulin sensitivity within a year. But longer-term, gastric banding should triumph.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Gastric Banding, Metformin Similar for Improving Glycemia
TUESDAY, Oct. 16, 2018 -- In adults with moderate obesity and either impaired glucose tolerance (IGT) or recently diagnosed mild type 2 diabetes (T2D), gastric banding and metformin are similarly effective for slowing disease progression over a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Diabetes Drug, Metformin, Might Help Shield the Heart From Smog's Ill Effects
THURSDAY, Oct. 11, 2018 -- The diabetes drug metformin may offer protection from heart attacks caused by smog, preliminary research suggests. Working with human lung tissue and mice, Northwestern University researchers found that metformin reduces... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 11, 2018 Category: General Medicine Source Type: news

Metformin Might Help Shield the Heart From Smog's Ill Effects
THURSDAY, Oct. 11, 2018 -- The diabetes drug metformin may offer protection from heart attacks caused by smog, preliminary research suggests. Working with human lung tissue and mice, Northwestern University researchers found that metformin reduces... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 11, 2018 Category: General Medicine Source Type: news

Gastric banding as effective as metformin in slowing prediabetes, type two diabetes
(NIH/National Institute of Diabetes and Digestive and Kidney Diseases) People with prediabetes or new-onset type 2 diabetes who had gastric banding, a type of bariatric surgery for weight loss, had similar stabilization of their disease to those who took metformin alone, according to a study supported by the National Institutes of Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2018 Category: International Medicine & Public Health Source Type: news

Gastric banding, metformin equally effective at stabilizing type 2 diabetes
Metformin, a longtime and low-cost drug, was as effective as gastric banding at stabilizing type 2 diabetes, though surgery is more effective for weight loss. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 3, 2018 Category: Consumer Health News Source Type: news

Gastric banding as effective as metformin in slowing progression of prediabetes, type 2 diabetes
NIH-funded study also finds the surgery more effective for weight loss than medication. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - October 3, 2018 Category: American Health Source Type: news

Recurrent Hypoglycemia Secondary to Metformin Toxicity Recurrent Hypoglycemia Secondary to Metformin Toxicity
This case demonstrates that significant hypoglycemia and severe lactic acidosis can develop after metformin ingestion, even without co-ingestion of other anti-diabetic drugs.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 3, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Study: Metformin useless in improving beta cell dysfunction in childhood diabetes
(Natural News) Another study shows yet another proof that pharmaceutical drugs are ineffective in addressing certain health conditions, particularly diabetes drugs. In a study published in the journal Diabetes Care, metformin and insulin failed to stop the decline of insulin production in newly diagnosed children with Type 2 diabetes. Researchers continue to search for ways... (Source: NaturalNews.com)
Source: NaturalNews.com - September 28, 2018 Category: Consumer Health News Source Type: news

Metformin and the Risk for Lactic Acidosis in CKD Metformin and the Risk for Lactic Acidosis in CKD
Dr Bansal reviews several studies that evaluate the safety of metformin in patients with chronic kidney disease.Medscape Nephrology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 21, 2018 Category: Intensive Care Tags: Nephrology Viewpoint Source Type: news

Medical News Today: Can people with type 2 diabetes stop taking metformin?
Metformin treats type 2 diabetes by lowering blood sugar levels. It is generally a safe and effective medication. However, metformin can cause side effects, and a person may be able to control their blood sugar by making lifestyle changes involving diet and exercise. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2018 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news

Big Data Confirm Type 2 Diabetes Treatment Approach Big Data Confirm Type 2 Diabetes Treatment Approach
Findings from a big-data analysis point to DPP-4 inhibitors as the safer choice for second-line treatment added to metformin in type 2 diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 31, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Metformin Hydrochloride Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - July 31, 2018 Category: Drugs & Pharmacology Source Type: news

Dizziness from standing up may mean higher risk of dementia
People with orthostatic hypotension in middle age had 54% higher risk of developing dementia Related items fromOnMedica Hypertension raises risk of mitral regurgitation Dementia and stroke funding remains too low, say experts Stroke can often be avoided, claims study Adding insulin to metformin linked to higher mortality Stroke rates rocket in younger men and women (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 26, 2018 Category: UK Health Source Type: news

Sulfonylureas As 2nd-Line T2DM Therapy Tied to Higher Event Risk
TUESDAY, July 24, 2018 -- Sulfonylureas as second-line drugs for type 2 diabetes are associated with an increased risk of cardiovascular and hypoglycemic events compared with remaining on metformin monotherapy or adding to metformin therapy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Diabetes: Switching to common drugs raises risk of complications
A new study finds that switching from metformin to sulfonylureas to control blood sugar levels may significantly increase the risk of major complications. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 19, 2018 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news

Switching from metformin to sulfonylurea linked to cardiometabolic complications
For type-2 diabetes patients, continuing metformin treatment together with sulfonylurea is safer than switching from one to the other, a study inThe BMJ reports.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 19, 2018 Category: Endocrinology Source Type: news

Adding or Switching Diabetes Drugs Can Put Patients at Risk: Study
THURSDAY, July 19, 2018 -- Using sulfonylurea drugs with or instead of metformin to control blood sugar increases type 2 diabetics'risk of serious complications, a new study finds. Metformin is a first-line treatment for type 2 diabetes, meaning it... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2018 Category: General Medicine Source Type: news

Raised risk of MI and mortality when starting sulfonylurea
Continuing metformin when introducing sulfonylureas in type 2 diabetes safer than switching Related items fromOnMedica Sugar not saturated fat is the major issue for CVD Experts query risks of pioglitazone Regulators suspend Avandia over safety concerns Daily aspirin use linked to major bleeding Use of DPP-4 inhibitors associated with increased risk of IBD (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 19, 2018 Category: UK Health Source Type: news

Switching From Metformin to Sulfonylurea Raises CV Risks Switching From Metformin to Sulfonylurea Raises CV Risks
In patients with type 2 diabetes not at glycemic goal, adding a sulfonylurea to metformin appears to be much safer than switching.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 18, 2018 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Metformin Beats Sulfonylureas for Heart Safety in T2D
(MedPage Today) -- MI risk seen with switch to sulfonylurea monotherapy or add-on treatment (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 18, 2018 Category: Primary Care Source Type: news

Two Regimens Fail to Stop Declines in & #946;-Cell Function
FRIDAY, July 13, 2018 -- Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of β-cell function in youth with impaired glucose tolerance (IGT) or recently-diagnosed type 2 diabetes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2018 Category: Pharmaceuticals Source Type: news

Metformin Tied to Acidosis Risk at eGFR & #60;30mL/min/1.73 m & #178;
WEDNESDAY, July 11, 2018 -- Metformin use is associated with an increased risk of acidosis at estimated glomerular filtration rate (eGFR)
Source: Drugs.com - Pharma News - July 11, 2018 Category: Pharmaceuticals Source Type: news

Standard type 2 diabetes treatments may not improve the condition in youth
Taking insulin or the most commonly used drug for type 2 diabetes, metformin, failed to either delay or effectively treat the condition in youth. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 10, 2018 Category: Universities & Medical Training Source Type: news

Metformin may help treatment of lung fibrosis
The diabetes drug could help reverse established lung fibrosis, a condition that currently lacks effective treatment options, according to a study inNature Medicine.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 4, 2018 Category: Endocrinology Source Type: news

Metformin reverses lung fibrosis in study with mice
Lung fibrosis was reversed in mice using metformin, a drug that has long been used to treat diabetes, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 3, 2018 Category: Consumer Health News Source Type: news

Sitagliptin-Metformin Therapy in Prior Gestational Diabetics Sitagliptin-Metformin Therapy in Prior Gestational Diabetics
Find out about the benefits treatment with sitagliptin combined with metformin may provide prediabetic women with a history of gestational diabetes.Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Youth-Onset Diabetes Needs Different Approach to That in Adults Youth-Onset Diabetes Needs Different Approach to That in Adults
Disturbing findings from the RISE study show that treating youth who have prediabetes with insulin and/or metformin doesn't prevent beta-cell deterioration; better treatments are needed, say physicians.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 27, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Metformin Linked to Lower Mortality in Diabetes With Dementia Metformin Linked to Lower Mortality in Diabetes With Dementia
A large registry study shows a 15% reduction in overall mortality among patients with diabetes and dementia who used metformin, while those taking insulin had an increased rate of heart failure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Early T2D Treatment in Youth Disappoints
(MedPage Today) -- Metformin, insulin didn't stop deterioration of beta-cells in adolescents with impaired glucose (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 25, 2018 Category: Cardiology Source Type: news